Literature DB >> 28561072

Immunotherapy: Macrophages hijack anti-PD-1 therapy.

David Killock.   

Abstract

Year:  2017        PMID: 28561072     DOI: 10.1038/nrclinonc.2017.79

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.

Authors:  Sean P Arlauckas; Christopher S Garris; Rainer H Kohler; Maya Kitaoka; Michael F Cuccarese; Katherine S Yang; Miles A Miller; Jonathan C Carlson; Gordon J Freeman; Robert M Anthony; Ralph Weissleder; Mikael J Pittet
Journal:  Sci Transl Med       Date:  2017-05-10       Impact factor: 17.956

  1 in total
  2 in total

1.  PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles Downregulate PD-1 Expression by Macrophages and Inhibit Tumor Growth : PD-1 siRNA-Encapsulated Solid Lipid Nanoparticles.

Authors:  Mahmoud S Hanafy; Stephanie Hufnagel; Andrea N Trementozzi; Wedad Sakran; Jeanne C Stachowiak; John J Koleng; Zhengrong Cui
Journal:  AAPS PharmSciTech       Date:  2021-01-31       Impact factor: 3.246

2.  CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer.

Authors:  Zhenguo Cheng; Danhua Zhang; Baocheng Gong; Pengliang Wang; Funan Liu
Journal:  Oncotarget       Date:  2017-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.